<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087098</url>
  </required_header>
  <id_info>
    <org_study_id>VEST-001</org_study_id>
    <nct_id>NCT02087098</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics</brief_title>
  <acronym>VEST</acronym>
  <official_title>Czech Observational Study to Evaluate Quality of Life in Patients Switched to Vesicare™ (Solifenacin) From Other Antimuscarinics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astellas Pharma Europe B.V.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astellas Pharma Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 12 month non-interventional study with solifenacin succinate, evaluating the effect
      of solifenacin on quality of life (QoL) of patients previously treated with antimuscarinics
      (Males and Females with Overactive Bladder (OAB) symptoms withdrawing their treatment with
      antimuscarinics because of safety and/or efficacy reasons) - measured by Perception of
      Treatment Satisfaction (TS-VAS) and to evaluate the effect of solifenacin on quality of life
      measured by Over Active Bladder-q Short Form (OAB-q SF), EuroQol Group scoring system
      (EQ-5D-5L).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of Over Active Bladder questionnaire Short Form (OAB-q SF) score</measure>
    <time_frame>baseline, month 6 and 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline of Patient Assessment of Treatment Satisfaction (TS-VAS)</measure>
    <time_frame>baseline, month 6 and 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in EuroQol Group system (EQ-5D-5L) score</measure>
    <time_frame>baseline, month 6 and 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in QoL according to previous antimuscarinic treatment and sex (assessed by: TS-VAS score, OAB-q SF score, EQ-5D-5L)</measure>
    <time_frame>baseline, month 1, 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in OAB symptoms assessed by micturition diary</measure>
    <time_frame>baseline, month 1, 3, 6 and 12</time_frame>
    <description>Mean number of urgency episode per 24 hours, mean number of micturition per 24 hours, mean number of nocturia episodes per 24 hours, mean number of urge incontinence (UUI) episodes per week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistence to therapy (measured by proportion of Days Covered (PDC, threshold of 80 percent during the measurement period), median length of therapy (days))</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of adverse drug reaction</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2000</enrollment>
  <condition>Urinary Bladder, Overactive</condition>
  <arm_group>
    <arm_group_label>Patients with residual OAB symptoms</arm_group_label>
    <description>Urge urinary incontinence, urgency, and frequency after treatment with other antimuscarinics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Solifenacin</intervention_name>
    <description>Patients with residual OAB symptoms (urge urinary incontinence, urgency, and frequency) after treatment with other antimuscarinics</description>
    <arm_group_label>Patients with residual OAB symptoms</arm_group_label>
    <other_name>Vesicare</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with OAB symptoms being treated by urologists in Czech Republic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient willing and able to complete the questionnaires

          -  Diagnosis of OAB

          -  Previous unsuccessful OAB medication (antimuscarinic treatment for at least 1 month)
             less than 4 weeks ago defined by:

               -  number of micturitions &gt; 8/24 h or

               -  decrease in urgency urinary incontinence (UUI) or incontinence episodes / 24 h
                  less than 50% or

               -  decrease in urgency episodes / 24 h less than 50% or

               -  decrease in number of micturitions / 24 h less than 20% or

               -  not acceptable tolerability

          -  Eligible to start Vesicare™ 5 or 10 mg according to Summary of Product Characteristics
             (SmPC)

        Exclusion Criteria:

          -  History of stress incontinence

          -  Active urinary tract infection (confirmed by positive urine analysis)

          -  Symptoms suggestive of severe Bladder Outlet Obstruction (BOO) defined as Peak urinary
             flow rate (Qmax) &lt; 10ml/sc and/or Postvoid residual urine volume (PVR) &gt; 150 ml

          -  Uncontrolled Diabetes Mellitus

          -  History of drug and/or alcohol abuse at the time of enrolment

          -  History of acute urinary retention, severe gastrointestinal obstruction (including
             paralytic ileus or intestinal atony or toxic megacolon or severe ulcerative colitis),
             myasthenia gravis, uncontrolled narrow glaucoma or swallow anterior chamber or deemed
             to be at risk for these conditions.

          -  Undergoing hemodialysis or has severe renal impairment or moderate hepatic impairment
             and who are on treatment with a potent CYP3A4 inhibitor

          -  Previous treatment with solifenacin

          -  Likely to participate in another study during study period of 12 months from study
             entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Use Central Contact</last_name>
    <role>Study Director</role>
    <affiliation>Astellas Pharma Europe B.V.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Site CZ42003 Private Practice</name>
      <address>
        <city>Benešov</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42001 Private Practice</name>
      <address>
        <city>Beroun</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42014 Private Practice</name>
      <address>
        <city>Blansko</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42023 Private Practice</name>
      <address>
        <city>Boskovice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42032 Private Practice</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42034 Hospital</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42035 Private Practice</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42036 Private Practice</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42038 Private Practice</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42039 Private Practice</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42058 Hospital</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42059 Hospital</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42025 Private Practice</name>
      <address>
        <city>Cheb</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42048 Private Practice</name>
      <address>
        <city>Dvůr Králové</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42040 Private Practice</name>
      <address>
        <city>Havlíčkův Brod</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42015 Private Practice</name>
      <address>
        <city>Hodonín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42045 Private Practice</name>
      <address>
        <city>Hradec Králové</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42027 Private Practice</name>
      <address>
        <city>Jindřichŭv Hradec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42029 Private Practice</name>
      <address>
        <city>Jindřichŭv Hradec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42051 Private Practice</name>
      <address>
        <city>Jičín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42026 Private Practice</name>
      <address>
        <city>Karlovy Vary</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42028 Private Practice</name>
      <address>
        <city>Karlovy Vary</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42030 Private Practice</name>
      <address>
        <city>Klatovy</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42049 Private Practice</name>
      <address>
        <city>Litoměřice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42021 Private Practice</name>
      <address>
        <city>Litovel</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42050 Private Practice</name>
      <address>
        <city>Most</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42054 Private Practice</name>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42055 Private Practice</name>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42056 Private Practice</name>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42057 Private Practice</name>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42005 Private Practice</name>
      <address>
        <city>Pardubice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42008 Private Practice</name>
      <address>
        <city>Pardubice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42024 Private Practice</name>
      <address>
        <city>Plzeň</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42011 Private Practice</name>
      <address>
        <city>Praha 10</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42006 Private Practice</name>
      <address>
        <city>Praha 2</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42010 Private Practice</name>
      <address>
        <city>Praha 4</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42009 Private Practice</name>
      <address>
        <city>Praha 5</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42004 Private Practice</name>
      <address>
        <city>Praha 7</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42002 Private Practice</name>
      <address>
        <city>Praha 8</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42007 Private Practice</name>
      <address>
        <city>Praha 8</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42060 Private Practice</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42044 Private Practice</name>
      <address>
        <city>Roudnice nad Labem</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42031 Private Practice</name>
      <address>
        <city>Strakonice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42020 Private Practice</name>
      <address>
        <city>Svitavy</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42047 Private Practice</name>
      <address>
        <city>Teplice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42053 Private Practice</name>
      <address>
        <city>Teplice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42042 Private Practice</name>
      <address>
        <city>Trutnov</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42052 Private Practice</name>
      <address>
        <city>Turnov</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42018 Hospital</name>
      <address>
        <city>Uherské Hradiště</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42019 Private Practice</name>
      <address>
        <city>Uherské Hradiště</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42041 Hospital</name>
      <address>
        <city>Velké Meziříčí</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42016 Private Practice</name>
      <address>
        <city>Vsetín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42017 Private Practice</name>
      <address>
        <city>Vsetín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42012 Private Practice</name>
      <address>
        <city>Zlín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42013 Private Practice</name>
      <address>
        <city>Zlín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42022 Private Practice</name>
      <address>
        <city>Zlín</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42033 Private Practice</name>
      <address>
        <city>Znojmo</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42037 Hospital</name>
      <address>
        <city>Znojmo</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42043 Private Practice</name>
      <address>
        <city>Ústí nad Labem</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site CZ42046 Private Practice</name>
      <address>
        <city>Ústí nad Labem</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>overactive bladder</keyword>
  <keyword>solifenacin</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Solifenacin Succinate</mesh_term>
    <mesh_term>Muscarinic Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

